LYNX CAPITAL GROUP LTD /ADV’s Boston Scientific BSX Stock Holding History

LYNX CAPITAL GROUP LTD /ADV’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$886K	Buy	+15,325	New	+$818K	0.65%	51

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LYNX CAPITAL GROUP LTD /ADV's BSX Position: Q4 2023 in Review

LYNX CAPITAL GROUP LTD /ADV opened a new position in Boston Scientific (BSX) in Q4 2023: 15,325 shares worth $886K. The stake represents 0.65% of the portfolio and ranks #51 among its holdings.

1,150 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

LYNX CAPITAL GROUP LTD /ADV held 15,325 shares of Boston Scientific worth $886K as of Q4 2023.
Boston Scientific was a new LYNX CAPITAL GROUP LTD /ADV position in Q4 2023.
Boston Scientific made up 0.65% of LYNX CAPITAL GROUP LTD /ADV's portfolio in Q4 2023, its #51 holding.
1,150 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on LYNX CAPITAL GROUP LTD /ADV's 13F filing for Q4 2023, filed 7 Aug 2026.